Epstein File EFTA00327843: JP Morgan and Tokyo (DS9)

Epstein Index›Documents›EFTA00327843

💨IMPACT LEVEL 1 — MEH

Epstein File EFTA00327843: JP Morgan and Tokyo (DS9)

CorrespondenceDate unavailableEFTA003278431 keyword hits

0

views

0

shares

0

reactions

0

persons

2

keywords

2

excerpts

This document is correspondence referencing a Series B institutional funding initiative launched during JP Morgan's Healthcare Conference in January 2016 in San Francisco, involving a corporate agreement with TerumoBCT, a division of Terumo Corporation (a publicly-traded medical device company headquartered in Tokyo with a $15 billion market capitalization). The message references 'Jeff P' in connection with the funding effort.

👤 Named in This Document

No named persons linked yet

🔑 Evidence Keywords

JP Morgan Tokyo

📋 Key Excerpts2

PersonKeyword

Excerpt 1

As you might know from Jeff P, we have kicked off an institutional Series B funding during the **JP** **Morgan** HC week (Jan 2016 in San Francisco).

Excerpt 2

Corporate Agreement with TerumoBCT, a division of Terumo Corporation (publicly-traded, global medical device company with a $15B market cap, headquartered in **Tokyo**